NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 44 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $689 | -77.0% | 3,723 | +51.5% | 0.00% | – |
| Q2 2022 | $3,000 | -85.7% | 2,457 | -67.0% | 0.00% | – |
| Q4 2021 | $21,000 | +10.5% | 7,436 | +43.5% | 0.00% | – |
| Q3 2021 | $19,000 | +1800.0% | 5,182 | +4406.1% | 0.00% | – |
| Q2 2021 | $1,000 | -95.5% | 115 | -96.1% | 0.00% | – |
| Q1 2021 | $22,000 | +15.8% | 2,929 | +4.2% | 0.00% | – |
| Q4 2020 | $19,000 | +72.7% | 2,812 | +92.7% | 0.00% | – |
| Q3 2020 | $11,000 | -77.6% | 1,459 | -74.1% | 0.00% | – |
| Q2 2020 | $49,000 | +4800.0% | 5,644 | +3931.4% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 140 | -59.5% | 0.00% | – |
| Q4 2019 | $2,000 | -89.5% | 346 | -90.8% | 0.00% | – |
| Q3 2019 | $19,000 | – | 3,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $14,169,000 | 0.85% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 103,500 | $723,000 | 0.55% |
| Sio Capital Management, LLC | 293,699 | $2,053,000 | 0.42% |
| GSA CAPITAL PARTNERS LLP | 121,389 | $849,000 | 0.14% |
| Frontier Wealth Management LLC | 145,000 | $1,014,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $2,174,000 | 0.06% |
| Oak Grove Capital LLC | 19,175 | $134,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 14,977 | $105,000 | 0.02% |
| Trexquant Investment LP | 15,479 | $108,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $138,000 | 0.01% |